Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  MedicationBG ControlType 1 DiabetesMedical DevicesInsulinGlucose MonitoringIssue 731

AACE: New Guidance on Insulin Pumps

In order for a patient to obtain maximum benefit from an insulin pump, uniform training programs must be developed.... 

Advertisement

George Grunberger, MD, president of AACE stated in an updated consensus statement that, "The organization acknowledges that pumps have become more sophisticated, and in order to obtain maximum benefit, training programs should be developed." According to that statement, which was published in Endocrine Practice, an update to earlier guidance from 2010 offered recommendations for patients who are on pump therapy with both type 1 and type 2 diabetes. It addresses the benefits of pump therapy, which include: pump therapy has benefits over multiple daily injections, better outcomes in regards to glycemic control, quality of life improvements, and severe hypoglycemia reductions.

The guidance provides an update on the state of technology and improvements to functional features of the pump. These improvements can be maximized if providers offer comprehensive training programs to patients.

Dr. Grunberger made several recommendations for creating a uniform training program including that the right people should be on the pumps and the people on pump therapy should be trained well. Some of the challenges in using pump therapy were also outlined including one of the biggest, that Medicare no longer covers CGM for pump therapy in patients over 65.

Practice Pearls:
  • Pump therapy has benefits over multiple daily injections, better outcomes in regards to glycemic control, quality of life improvements, and severe hypoglycemia reductions.
  • The guidance provides an update on the state of technology and improvements to functional features of the pump.
  • Medicare no longer covers CGM for pump therapy in patients over 65

Grunberger G, et al "Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force" Presented at the 2014 AACE meeting. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 29 May, 2014 and appeared in  MedicationBG ControlType 1 DiabetesMedical DevicesInsulinGlucose MonitoringIssue 731

Past five issues: Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 | Diabetes Clinical Mastery Series Issue 223 |

2014 Most Popular Articles:

ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014
Why a Low-Carb Diet Should Be the First Approach in Diabetes Treatment
Posted December 18, 2014
Advancement in the Artificial Pancreas
Posted December 26, 2014
FDA Approves Weight-management Drug Saxenda
Posted December 26, 2014
Type 2 Diabetes Risk Lower for Blood Type O
Posted December 26, 2014
Handbook of Diabetes, 4th Ed., Excerpt #25: Specific Circumstances that Affect Diabetes Control
Posted January 04, 2015
Early Insulin Therapy Makes an Impact
Posted December 26, 2014
Increased Mortality with Combining Sulfonylurea and Insulin
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Are you comfortable recommending one of the 4 new FDA-approved weight loss drugs?
CME/CE of the Week
Vickie Driver, DPM, MS, FACFAS

Category: Wound Care
Credits: 1.0



Search Articles On Diabetes In Control